Jones Caroline E, Graham Laura A, Morris Melanie S, Richman Joshua S, Hollis Robert H, Wahl Tyler S, Copeland Laurel A, Burns Edith A, Itani Kamal M F, Hawn Mary T
University of Alabama-Birmingham, Department of Surgery; Birmingham Veterans Administration Hospital, Birmingham.
Central Texas Veterans Health Care System, Temple.
JAMA Surg. 2017 Nov 1;152(11):1031-1038. doi: 10.1001/jamasurg.2017.2350.
Preoperative hyperglycemia is associated with adverse postoperative outcomes among patients who undergo surgery. Whether preoperative hemoglobin A1c (HbA1c) or postoperative glucose levels are more useful in predicting adverse events following surgery is uncertain in the current literature.
To examine the use of preoperative HbA1c and early postoperative glucose levels for predicting postoperative complications and readmission.
DESIGN, SETTING, AND PARTICIPANTS: In this observational cohort study, inpatient gastrointestinal surgical procedures performed at 117 Veterans Affairs hospitals from 2007 to 2014 were identified, and cases of known infection within 3 days before surgery were excluded. Preoperative HbA1c levels were examined as a continuous and categorical variable (<5.7%, 5.7%-6.5%, and >6.5%). A logistic regression modeled postoperative complications and readmissions with the closest preoperative HbA1c within 90 days and the highest postoperative glucose levels within 48 hours of undergoing surgery.
Postoperative complications and 30-day unplanned readmission following discharge.
Of 21 541 participants, 1193 (5.5%) were women, and the mean (SD) age was 63.7 (10.6) years. The cohort included 23 094 operations with measurements of preoperative HbA1c levels and postoperative glucose levels. The complication and 30-day readmission rates were 27.2% and 14.7%, respectively. In logistic regression models adjusting for HbA1c, postoperative glucose levels, postoperative insulin use, diabetes, body mass index (calculated as weight in kilograms divided by height in meters squared), and other patient and procedural factors, peak postoperative glucose levels of more than 250 mg/dL were associated with increased 30-day readmissions (odds ratio, 1.18; 95% CI, 0.99-1.41; P = .07). By contrast, a preoperative HbA1c of more than 6.5% was associated with decreased 30-day readmissions (odds ratio, 0.85; 95% CI, 0.74-0.96; P = .01). As preoperative HbA1c increased, the frequency of 48-hour postoperative glucose checks increased (4.92, 6.89, and 9.71 for an HbA1c <5.7%, 5.7%-6.4%, and >6.5%, respectively; P < .001). Patients with a preoperative HbA1c of more than 6.5% had lower thresholds for postoperative insulin use.
Early postoperative hyperglycemia was associated with increased readmission, but elevated preoperative HbA1c was not. A higher preoperative HbA1c was associated with increased postoperative glucose level checks and insulin use, suggesting that heightened postoperative vigilance and a lower threshold to treat hyperglycemia may explain this finding.
术前高血糖与接受手术患者的术后不良结局相关。目前的文献中尚不确定术前糖化血红蛋白(HbA1c)或术后血糖水平在预测术后不良事件方面哪个更有用。
研究术前HbA1c和术后早期血糖水平对预测术后并发症和再入院的作用。
设计、背景和参与者:在这项观察性队列研究中,确定了2007年至2014年在117家退伍军人事务医院进行的住院胃肠外科手术,并排除术前3天内已知感染的病例。术前HbA1c水平作为连续和分类变量进行检查(<5.7%、5.7%-6.5%和>6.5%)。采用逻辑回归模型,以手术前90天内最接近的术前HbA1c和手术后48小时内最高的术后血糖水平为变量,对术后并发症和再入院情况进行建模。
术后并发症和出院后30天内的非计划再入院。
21541名参与者中,1193名(5.5%)为女性,平均(标准差)年龄为63.7(10.6)岁。该队列包括23094例手术,均测量了术前HbA1c水平和术后血糖水平。并发症发生率和30天再入院率分别为27.2%和14.7%。在调整了HbA1c、术后血糖水平、术后胰岛素使用、糖尿病、体重指数(以千克体重除以身高米的平方计算)以及其他患者和手术因素的逻辑回归模型中,术后血糖峰值超过250mg/dL与30天再入院率增加相关(比值比,1.18;95%置信区间,0.99-1.41;P=0.07)。相比之下,术前HbA1c超过6.5%与30天再入院率降低相关(比值比,0.85;95%置信区间,0.74-0.96;P=0.01)。随着术前HbA1c升高,术后48小时血糖检查频率增加(HbA1c<5.7%、5.7%-6.4%和>6.5%的患者分别为4.92、6.89和9.71次;P<0.001)。术前HbA1c超过6.5%的患者术后胰岛素使用阈值较低。
术后早期高血糖与再入院率增加相关,但术前HbA1c升高则不然。术前较高的HbA1c与术后血糖水平检查和胰岛素使用增加相关,这表明术后更高的警惕性和更低的高血糖治疗阈值可能解释了这一发现。